RGNX Operating Income Growth
Regenxbio Inc · Operating Income Growth
RGNX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported0.27%period ending
RGNX TTM Operating Income YoY % (-525.66% → 0.27%)
Year-over-year change
High-resolution chart · PNG
RGNX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 0.274% | |
| -63.125% | |
| 30.2912% | |
| 36.4468% | |
| 33.2702% | |
| 40.3351% | |
| 13.7557% | |
| 6.9528% | |
| 7.9897% | |
| -2.4182% | |
| -1.9979% | |
| -341.491% | |
| -319.4004% | |
| -294.3515% | |
| -264.318% | |
| 152.3436% | |
| 189.8653% | |
| 205.5107% | |
| 234.1743% | |
| -95.7085% | |
| 12.7028% | |
| 16.723% | |
| 19.9768% | |
| 0.2994% | |
| -67.381% | |
| -202.6068% | |
| -269.1237% | |
| -253.8319% | |
| -232.05% | |
| -201.5674% | |
| 216.0967% | |
| 186.5791% | |
| 191.3804% | |
| 163.7078% | |
| -16.1387% | |
| -58.334% | |
| -97.4725% | |
| -153.3673% | |
| -182.4048% | |
| -153.7249% | |
| -174.8715% | |
| -257.0841% | |
| -525.6625% |